Kawata AK, Ladd MK, Lipton RB, Buse DC, et al. Reducing the physical, social, and emotional impact of episodic migraine: Results from erenumab STRIVE and ARISE phase III randomized trials. Headache 2022 Feb 8. doi: 10.1111/head.14258.
PMID: 35137394